Search Results - "Belderbos, J S A"

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study by BAAS, P, BELDERBOS, J. S. A, SENAN, S, KWA, H. B, VAN BOCHOVE, A, VAN TINTEREN, H, BURGERS, J. A, VAN MEERBEECK, I. P

“…To improve the prognosis of limited stage small cell lung cancer (LS-SCLC) the addition of concurrent thoracic radiotherapy to a platinum-containing regimen is…”
Get full text

Involved field radiotherapy for locally advanced non-small cell lung cancer: Isolated mediastinal nodal relapse by Vanneste, B.G.L, Haas, R.L.M, Bard, M.P.L, Rijna, H, Váldes Olmos, R.A, Belderbos, J.S.A

“…Abstract The current standard of care for locally advanced inoperable non-small cell lung cancer is high dose radiotherapy with concurrent chemotherapy. We…”
Get full text

Treatment Variation of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients in the Netherlands and Belgium by Walraven, I., Damhuis, R.A., ten Berge, M.G., Rosskamp, M., van Eycken, L., de Ruysscher, D., Belderbos, J.S.A.

“…Concurrent chemoradiotherapy (CCRT) is considered the standard treatment regimen in non-surgical locally advanced non-small cell lung cancer (NSCLC) patients…”
Get full text

Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial by Konert, T., Vogel, W. V., Paez, D., Polo, A., Fidarova, E., Carvalho, H., Duarte, P. S., Zuliani, A. C., Santos, A. O., Altuhhova, D., Karusoo, L., Kapoor, R., Sood, A., Khader, J., Al-Ibraheem, A., Numair, Y., Abubaker, S., Soydal, C., Kütük, T., Le, T. A., Canh, N. X., Bieu, B. Q., Ha, L. N., Belderbos, J. S. A., MacManus, M. P., Thorwarth, D., Hanna, G. G.

“…Purpose Patients with stage III non-small-cell lung cancer (NSCLC) treated with chemoradiotherapy (CRT) in low- and middle-income countries (LMIC) continue to…”
Get full text

From Cisplatin-Containing Sequential Radiochemotherapy towards Concurrent Treatment for Patients with Inoperable Locoregional Non-Small Cell Lung Cancer: Still Unanswered Questions by Koning, C. C. E., Belderbos, J. S. A., Uitterhoeve, A. L. J.

“…Radiotherapy has been the mainstay of the treatment of stage III non-small cell lung cancer (NSCLC) patients. In the early nineties, combined treatment with…”
Get full text

Non-small cell lung carcinoma of the superior sulcus: Favourable outcomes of combined modality treatment in carefully selected patients by Kappers, I, Belderbos, J.S.A, Burgers, J.A, van Zandwijk, N, Groen, H.J.M, Klomp, H.M

“…Summary The combination of radiotherapy and concurrent chemotherapy followed by surgery (trimodality treatment) is currently regarded as optimal treatment for…”
Get full text

Lower dose radiotherapy did not alter cardiac function and was not pro-arrhythmic: results of the small prospective HALO trial by Hoeksema, W F, Belderbos, J S A, Dieleman, E M T, Hopman, L H G, Van Doorn, C J, De Bruin, H A C M, Van Der Ree, M H, Visser, J, Van Kesteren, Z, Postema, P G, Boekholdt, S M, Planken, R N, Sonke, J J, Stam, B

“…Abstract Background Stereotactic arrhythmia radiotherapy (STAR) is a highly promising bail-out treatment for patients with therapy-refractory ventricular…”
Get full text

Fusion of respiration-correlated PET and CT scans: correlated lung tumour motion in anatomical and functional scans by Wolthaus, J W H, van Herk, M, Muller, S H, Belderbos, J S A, Lebesque, J V, de Bois, J A, Rossi, M M G, Damen, E M F

“…Lower lobe lung tumours in particular can move up to 2 cm in the cranio-caudal direction during the respiration cycle. This breathing motion causes image…”
Get more information

Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer by Seppenwoolde, Y, Muller, S H, Theuws, J C, Baas, P, Belderbos, J S, Boersma, L J, Lebesque, J V

“…To determine local dose-effect relations for lung perfusion and density changes due to irradiation for patients with non-small-cell lung cancer (NSCLC) and to…”
Get more information

Perspectives in the treatment of non-small cell lung cancer stage III with radiotherapy and concomitant low-dosage chemotherapy by Uitterhoeve, A L J, Belderbos, J S A, van Zandwijk, N, Koning, C C E

“…Patients with a non-small cell lung cancer stage III should preferably be treated with a combination of concomitant radiotherapy and platinum-containing…”
Get more information

Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study by Uitterhoeve, A.L.J., Belderbos, J.S.A., Koolen, M.G.J., van der Vaart, P.J.M., Rodrigus, P.T.R., Benraadt, J., Koning, C.C.M., González González, D., Bartelink, H.

“…The purpose of this work was to study the feasibility of concurrent chemoradiation in patients with inoperable non-small cell lung cancer (NSCLC). 40 patients…”
Get full text